Marathon Pharmaceuticals
id:
marathon-pharmaceuticals-200-1264639
title:
Marathon Pharmaceuticals
text:
Marathon Pharmaceuticals LLC was a privately held biopharmaceuticals company focused on drugs for people with rare diseases. The Illinois-based company developed and manufactured therapeutics and brought them to market. It employed 100 people in four global locations. In 2017, PTC Therapeutics acquired rights to Marathon Pharmaceuticals' drug Emflaza (deflazacort) for $140 million after criticism about their plan to sell the drug at a list price of $89,000 per year to sufferers despite the fact
brand slug:
wiki
category slug:
encyclopedia
description:
Former U.S. rare disease drug company
original url:
https://en.wikipedia.org/wiki/Marathon_Pharmaceuticals
date created:
date modified:
2023-05-05T22:49:52Z
main entity:
{"identifier":"Q18352506","url":"https://www.wikidata.org/entity/Q18352506"}
image:
fields total:
13
integrity:
14